These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 29653085)

  • 1. Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: A propensity score matching analysis.
    Chen S; Yan H; Du J; Li J; Shen B; Ying H; Zhang Y; Chen S
    Clin Chim Acta; 2018 Jul; 482():203-208. PubMed ID: 29653085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinum-based chemotherapy.
    Ying J; Zhou D; Gu T; Huang J; Liu H
    BMC Cancer; 2019 Mar; 19(1):288. PubMed ID: 30925910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albumin-to-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals.
    Li SQ; Jiang YH; Lin J; Zhang J; Sun F; Gao QF; Zhang L; Chen QG; Wang XZ; Ying HQ
    Cancer Med; 2018 Apr; 7(4):1221-1231. PubMed ID: 29533009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Preoperative Albumin-to-Fibrinogen Ratio in Patients with Bladder Cancer.
    Li S; Zhang D; Zeng S; Wu T; Wang Y; Zhang H; Wang B; Hu X
    J Cancer; 2021; 12(19):5864-5873. PubMed ID: 34475999
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum uric acid to lymphocyte ratio: A novel prognostic biomarker for surgically resected early-stage lung cancer. A propensity score matching analysis.
    Yang Z; Li S; Zhao L; Lv W; Ju J; Zhang W; Li J; Che G
    Clin Chim Acta; 2020 Apr; 503():35-44. PubMed ID: 31926813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin-to-alkaline phosphatase ratio as a novel prognostic indicator for patients undergoing minimally invasive lung cancer surgery: Propensity score matching analysis using a prospective database.
    Li SJ; Lv WY; Du H; Li YJ; Zhang WB; Che GW; Liu LX
    Int J Surg; 2019 Sep; 69():32-42. PubMed ID: 31319230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
    Hyun SH; Choi JY; Kim K; Kim J; Shim YM; Um SW; Kim H; Lee KH; Kim BT
    Ann Surg; 2013 Feb; 257(2):364-70. PubMed ID: 22968069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel systemic inflammation response index to predict prognosis after thoracoscopic lung cancer surgery: a propensity score-matching study.
    Li S; Yang Z; Du H; Zhang W; Che G; Liu L
    ANZ J Surg; 2019 Nov; 89(11):E507-E513. PubMed ID: 31667974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of the preoperative albumin/globulin and monocyte ratio in resected early-stage non-small cell lung cancer.
    Wu W; Zhang L; Wang C; Xu Z; Feng C; Zhang Z; Qin D; Zhang C; Lin F
    Asian J Surg; 2024 Jan; 47(1):118-123. PubMed ID: 37419798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gustave Roussy Immune Score based on a three-category risk assessment scale serves as a novel and effective prognostic indicator for surgically resectable early-stage non-small-cell lung cancer: A propensity score matching retrospective cohort study.
    Li SJ; Zhao L; Wang HY; Zhou HN; Ju J; Du H; Che GW
    Int J Surg; 2020 Dec; 84():25-40. PubMed ID: 33086147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
    Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
    Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prognostic Value of Pre-treatment Albumin/Fibrinogen Ratio in Patients with Diffuse Large B-cell Lymphoma].
    Deng H; Zhang L; Wang HY; Huang MJ; Wei J; Zou XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):762-768. PubMed ID: 37356937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
    Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
    J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment Albumin-to-Fibrinogen Ratio is a Promising Biomarker for Predicting Postoperative Clinical Outcomes in Patients with Colorectal Cancer.
    Xie H; Yuan G; Liu M; Huang S; Wei L; Tang S; Gan J
    Nutr Cancer; 2022; 74(8):2896-2909. PubMed ID: 35193433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer.
    Shoji F; Morodomi Y; Akamine T; Takamori S; Katsura M; Takada K; Suzuki Y; Fujishita T; Okamoto T; Maehara Y
    Lung Cancer; 2016 Aug; 98():15-21. PubMed ID: 27393501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
    Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
    Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected.
    Ren Y; Dai C; Shen J; Liu Y; Xie D; Zheng H; He J; Liang W; Jiang G; Fei K; Yang P; He J; Chen C
    Oncotarget; 2016 May; 7(18):26856-65. PubMed ID: 27057627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of preoperative metabolic tumor volumes on PET-CT in predicting disease-free survival of patients with stage I non-small cell lung cancer.
    Lin Y; Lin WY; Kao CH; Yen KY; Chen SW; Yeh JJ
    Anticancer Res; 2012 Nov; 32(11):5087-91. PubMed ID: 23155285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
    Fan J; Yu H; Lv Y; Yin L
    Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.